---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-021028"
form_type: "8-K"
ticker: "CURX"
cik: "0002025942"
company_name: "Curanex Pharmaceuticals Inc"
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-17T00:03:19.409299+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Curanex Pharmaceuticals receives Nasdaq bid price deficiency notice; 180-day cure period

## Summary
- Received Nasdaq notice on Nov 5, 2025 for bid price below $1.00 for 30 consecutive days.
- Has until May 4, 2026 (180 days) to regain compliance with Minimum Bid Price.
- If not cured, may qualify for additional 180-day period if eligible and cures with reverse split if needed.
- Stock continues trading under symbol CURX on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001493152-25-021028
- form_type: 8-K
- ticker: CURX
- cik: 0002025942
- company_name: Curanex Pharmaceuticals Inc
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2025942/000149315225021028/0001493152-25-021028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2025942/000149315225021028/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-021028
- JSON: https://secwatch.observer/filing/0001493152-25-021028.json
- Plain text: https://secwatch.observer/filing/0001493152-25-021028.txt

## Source-grounded claims
- claim_id: 54192e7d53ccc770b60ff230440e7bac8a254c0a
  claim: Curanex Pharmaceuticals Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  evidence_excerpt: November 5, 2025, Curanex Pharmaceuticals Inc, a Nevada corporation (the “Company”), received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”), was below $1.00 per share, which is the minimum closing bid price (the “Minimum Bid Price”) required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Notice”). This Notice has no immediate
  evidence_url: https://www.sec.gov/Archives/edgar/data/2025942/000149315225021028/0001493152-25-021028-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.